首页> Clinical infectious diseases> 10 × '20 progress - Development of new drugs active against gram-negative bacilli: An update from the infectious diseases society of America

10 × '20 progress - Development of new drugs active against gram-negative bacilli: An update from the infectious diseases society of America

导出原文传递

翻译打印收藏纠错

第一作者： Boucher,H.W.

作者： Boucher,H.W. ^[1] ; Talbot,G.H. ^[2] ; Benjamin,D.K. ^[3] ; Bradley,J. ^[4] ; Guidos,R.J. ^[5] ; Jones,R.N. ^[6] ; Murray,B.E. ^[7] ; Bonomo,R.A. ^[8] ; Gilbert,D. ^[9]

作者单位： Division of Infectious Diseases, University of Texas Medical School at Houston, United States ^[1] JMI Laboratories, North Liberty, IA, United States, Tufts University School of Medicine, Boston, MA ^[2] Division of Infectious Diseases, Providence Portland Medical Center, United States, Oregon Health ^[3] Division of Geographic Medicine and Infectious Diseases, Tufts University School of Medicine, Tufts ^[4] Talbot Advisors, Anna Maria, FL, United States ^[5] Public Policy and Government Relations, Infectious Diseases Society of America, 1300 Wilson Blvd ^[6] Research Service, Louis Stokes Cleveland Department of Veterans Affairs Medical Center, United ^[7] Duke University School of Medicine, United States, Duke Clinical Research Institute, Durham, NC ^[8] Division of Infectious Diseases, Children's Hospital San Diego, United States, Division of ^[9]

关键词 antibacterial agents antibiotic pipeline antimicrobials clinical trials drug development gram-negative bacilli

发布时间 2013-11-20

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交